![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1421091
¼¼°èÀÇ ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)Global Medical Oxygen Concentrators Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
¼¼°è ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀå ±Ô¸ð´Â 2023³â 55¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2024-2032³â ¿¬Æò±Õ 7.6% ¼ºÀåÇÏ¿© 2032³â¿¡´Â ¾à 106¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÇ·á¿ë »ê¼Ò¹ß»ý±â´Â È£Èí±â ÁúȯÀ» ¾Î°í Àְųª º¸Á¶ »ê¼Ò ¿ä¹ýÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ÁýÁßÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇϱâ À§ÇØ Æ¯º°È÷ °í¾ÈµÈ ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ ÀåÄ¡´Â ÁÖº¯ °ø±â¸¦ ÈíÀÔÇÏ°í ´Ù¸¥ °¡½º¸¦ Á¦°ÅÇÏ¿© ȯÀÚ¿¡°Ô °í³óµµÀÇ »ê¼Ò¸¦ °ø±ÞÇÕ´Ï´Ù.
ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖÀ¸¸ç, COPD ¹× õ½Ä°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÇÔ²² Àü ¼¼°è Àα¸ÀÇ °í·ÉȰ¡ ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. »ê¼Ò ¿ä¹ýÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ³óÃà±â ¼³°è¸¦ °³¼±ÇÏ´Â ±â¼ú ¹ßÀü, ÀçÅà °£È£ ȯ°æ¿¡ ´ëÇÑ ¼±È£µµ°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, COVID-19 ÆÒµ¥¹ÍÀº »ê¼Ò ¿ä¹ý¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̰í ÀÇ·á ½Ã¼³°ú °¡Á¤ ¸ðµÎ¿¡¼ ÀÇ·á¿ë »ê¼Ò¹ß»ý±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁõÆø½Ã۰í ÀÖ½À´Ï´Ù. Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê, ÀÇ·áºñ Áõ°¡, »ýȰ½À°ü º¯È ¹× ȯ°æÀû ¿äÀΰú °°Àº ¼¼°è °Ç° µ¿ÇâÀº ½ÃÀå Çü¼º¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼ú ¹ßÀü, Àú·ÅÇÑ °¡°Ý, ÀÇ·á ÀÎÇÁ¶ó °³¼± ³ë·ÂÀ¸·Î ÀÎÇØ ½ÅÈï ½ÃÀå¿¡¼ ÀÇ·á¿ë »ê¼Ò¹ß»ý±â äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ÇÑÆí, ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀåÀÇ ÁøÈÇϴ ȯ°æ¿¡¼ °æÀï ¹× ±ÔÁ¦ ȯ°æ°ú °°Àº µµÀü °úÁ¦¸¦ °í·ÁÇØ¾ß ÇÕ´Ï´Ù.
Á¶»ç º¸°í¼´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ¼¼°è ½ÃÀå¿¡¼ °¢ ºÎ¹®À» Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á¿ë »ê¼Ò¹ß»ý±â »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.
ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀå º¸°í¼ÀÇ ÀÌ ¼½¼Ç¿¡¼´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ »ó¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·« ´ã´çÀÚ°¡ °¢ Á¦Ç° ¹× ¼ºñ½ºÀÇ Å¸°ÙÃþÀ» ½Äº°Çϰí ÇâÈÄ ºñÁö´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
ÀÌ ¼½¼Ç¿¡¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °¢ ÀÀ¿ë ºÐ¾ß¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼¸¦ Á¦°ø ÇÒ ¼ö ÀÖ½À´Ï´Ù.
The global demand for Medical Oxygen Concentrators Market is presumed to reach the market size of nearly USD 10.69 Billion by 2032 from USD 5.53 Billion in 2023 with a CAGR of 7.6% under the study period 2024 - 2032.
Medical oxygen concentrators are devices designed specifically to deliver a focused stream of oxygen to individuals with respiratory conditions or require supplemental oxygen therapy. These devices take in ambient air, remove other gases, and provide a higher concentration of oxygen to the patient.
The medical oxygen concentrators market is propelled by various factors contributing to its continual expansion. An aging global population, coupled with a rising prevalence of respiratory disorders like COPD and asthma, fuels the demand for these devices. Increased awareness of the benefits of oxygen therapy, advancements in technology enhancing concentrator design, and the preference for homecare settings further contribute to market growth. The COVID-19 pandemic has increased oxygen therapy awareness, amplifying the demand for medical oxygen concentrators both in healthcare facilities and for home use. Government initiatives, rising healthcare expenditure, and global health trends, such as lifestyle changes and environmental factors, play pivotal roles in shaping the market. Additionally, the adoption of medical oxygen concentrators is increasing in emerging markets due to technological advancements, affordability, and efforts to improve healthcare infrastructure. While these factors drive market expansion, challenges such as competition and regulatory compliance need consideration in the evolving landscape of the medical oxygen concentrators market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of medical oxygen concentrators. The growth and trends of medical oxygen concentrators industry provide a holistic approach to this study.
This section of the medical oxygen concentrators market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Medical Oxygen Concentrators market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Oxygen Concentrators market include ResMed Inc., Philips Respironics (a Division Of Royal Philips), Invacare Corporation, Inogen Inc., Drive DeVilbiss Healthcare, Chart Industries, Nidek Medical Products Inc., Teijin Limited, Precision Medical, Inc., GCE Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.